Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Reported mild effects include: Commonly Reported Mild headaches: Some users report transient headaches, particularly in the first few days of use Anxiety or nervousness: A subset of users report increased anxiety, social anxiety, or a "jittery" sensation Overstimulation: Feeling mentally "wired," racing thoughts, or difficulty focusing despite cognitive goals Sleep disruption: Occasional reports of insomnia or vivid dreams if taken late in the day covered in depth in Dihexa, Sleep & Memory Consolidation: Vivid Dreams, REM & the 2026 Neuroscience Review, including parasomnia red flags and a practical dose-timing protocol Mood fluctuations: Some reports of subtle mood changes, though the direction (improvement vs
refer to COA for component ratio per capsule) Strength: 2 mg total peptide content per capsule Count: 60 capsules per bottle Purity: 99% (HPLC verified, each component) Container: sealed amber bottle Certificate of Analysis: lot-specific COA available, with separate purity and identity verification for all three component peptides See the FDA Disclosure, Storage Instructions, and RUO tabs for handling, storage, and regulatory information
in a research context, they simply target the problem from completely different angles
Injection sites should be rotated between deltoid, vastus lateralis, and ventrogluteal locations to prevent tissue damage
